OVERVIEW Elite wellness is fragmenting into two camps: traditional luxury (Equinox, Soho House wellness) and quantified-self optimization (continuous glucose monitoring, genetic testing, performance coaching). The $1.5T global wellness market is consolidating around longevity medicine and personalized biodata tracking, with high-net-worth individuals treating health as a competitive advantage rather than a lifestyle choice. KEY SIGNALS Direct-to-consumer longevity clinics opened 40% more locations in 2024. Employers increasingly cover genetic screening and continuous monitoring. Celebrity venture capitalists are backing biotech startups focused on aging reversal, signaling conviction capital. NYC boutique fitness saw 8% decline while preventive health concierge services grew 25% YoY. WHAT TO WATCH Monitor insurance coverage shifts—major insurers considering reimbursement for preventive biohacking. Watch for corporate wellness program pivots toward personalized medicine. Track real estate implications: expect 'wellness hubs' in luxury buildings with on-site biomarker testing and genetic counseling becoming amenity expectations in high-end NYC properties.
This is a members-only intelligence brief from Yesodi. Join to read the full analysis, discuss with community members, and access all briefs.
Join Yesodi →